Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer

被引:352
作者
Brenner, J. Chad [1 ,2 ,3 ]
Ateeq, Bushra [1 ,2 ]
Li, Yong [1 ,2 ]
Yocum, Anastasia K. [1 ,2 ,8 ]
Cao, Qi [1 ,2 ]
Asangani, Irfan A. [1 ]
Patel, Sonam [1 ]
Wang, Xiaoju [1 ,2 ]
Liang, Hallie [1 ]
Yu, Jindan [1 ,2 ,7 ]
Palanisamy, Nallasivam [1 ,2 ,9 ]
Siddiqui, Javed [1 ,2 ,7 ]
Yan, Wei [1 ,2 ]
Cao, Xuhong [1 ,4 ]
Mehra, Rohit [1 ,2 ]
Sabolch, Aaron [5 ]
Basrur, Venkatesha [1 ,2 ]
Lonigro, Robert J. [1 ,2 ]
Yang, Jun [10 ,11 ]
Tomlins, Scott A. [1 ,2 ]
Maher, Christopher A. [1 ,2 ,6 ]
Elenitoba-Johnson, Kojo S. J. [2 ]
Hussain, Maha [7 ,8 ,9 ]
Navone, Nora M. [10 ,11 ]
Pienta, Kenneth J. [1 ,3 ,7 ,8 ,9 ]
Varambally, Sooryanarayana [1 ,2 ,8 ]
Feng, Felix Y. [1 ,5 ,9 ]
Chinnaiyan, Arul M. [1 ,2 ,3 ,4 ,8 ,9 ]
机构
[1] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA
[7] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[9] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[11] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
EWINGS-SARCOMA TRANSLOCATION; DNA-LIGASE IV; TRANSCRIPTION FACTORS; TMPRSS2-ERG FUSION; ANDROGEN RECEPTOR; EWS GENE; EXPRESSION; TUMORS; PROGRESSION; ERG;
D O I
10.1016/j.ccr.2011.04.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrent fusions of ETS genes are considered driving mutations in a diverse array of cancers, including Ewing's sarcoma, acute myeloid leukemia, and prostate cancer. We investigate the mechanisms by which ETS fusions mediate their effects, and find that the product of the predominant ETS gene fusion, TMPRSS2:ERG, interacts in a DNA-independent manner with the enzyme poly (ADP-ribose) polymerase 1 (PARP1) and the catalytic subunit of DNA protein kinase (DNA-PKcs). ETS gene-mediated transcription and cell invasion require PARP1 and DNA-PKcs expression and activity. Importantly, pharmacological inhibition of PARP1 inhibits ETS-positive, but not ETS-negative, prostate cancer xenograft growth. Finally, overexpression of the TMPRSS2:ERG fusion induces DNA damage, which is potentiated by PARP1 inhibition in a manner similar to that of BRCA1/2 deficiency.
引用
收藏
页码:664 / 678
页数:15
相关论文
共 55 条
[11]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042
[12]   PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles [J].
Ellisen, Leif W. .
CANCER CELL, 2011, 19 (02) :165-167
[13]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921
[14]   Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].
Fong, Peter C. ;
Boss, David S. ;
Yap, Timothy A. ;
Tutt, Andrew ;
Wu, Peijun ;
Mergui-Roelvink, Marja ;
Mortimer, Peter ;
Swaisland, Helen ;
Lau, Alan ;
O'Connor, Mark J. ;
Ashworth, Alan ;
Carmichael, James ;
Kaye, Stan B. ;
Schellens, Jan H. M. ;
de Bono, Johann S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134
[15]   Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV [J].
Frank, KM ;
Sekiguchi, JM ;
Seidl, KJ ;
Swat, W ;
Rathbun, GA ;
Cheng, HL ;
Davidson, L ;
Kangaloo, L ;
Alt, FW .
NATURE, 1998, 396 (6707) :173-177
[16]   Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer [J].
Gallagher, David J. ;
Gaudet, Mia M. ;
Pal, Prodipto ;
Kirchhoff, Tomas ;
Balistreri, Lisa ;
Vora, Kinjal ;
Bhatia, Jasmine ;
Stadler, Zsofia ;
Fine, Samson W. ;
Reuter, Victor ;
Zelefsky, Michael ;
Morris, Michael J. ;
Scher, Howard I. ;
Klein, Robert J. ;
Norton, Larry ;
Eastham, James A. ;
Scardino, Peter T. ;
Robson, Mark E. ;
Offit, Kenneth .
CLINICAL CANCER RESEARCH, 2010, 16 (07) :2115-2121
[17]   Structural studies of Ets-1/Pax5 complex formation on DNA [J].
Garvie, CW ;
Hagman, J ;
Wolberger, C .
MOLECULAR CELL, 2001, 8 (06) :1267-1276
[18]   Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements [J].
Haffner, Michael C. ;
Aryee, Martin J. ;
Toubaji, Antoun ;
Esopi, David M. ;
Albadine, Roula ;
Gurel, Bora ;
Isaacs, William B. ;
Bova, G. Steven ;
Liu, Wennuan ;
Xu, Jianfeng ;
Meeker, Alan K. ;
Netto, George ;
De Marzo, Angelo M. ;
Nelson, William G. ;
Yegnasubramanian, Srinivasan .
NATURE GENETICS, 2010, 42 (08) :668-U45
[19]   Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer [J].
Helgeson, Beth E. ;
Tomlins, Scott A. ;
Shah, Nameeta ;
Laxman, Bharathi ;
Cao, Qi ;
Prensner, John R. ;
Cao, Xuhong ;
Singla, Nirmish ;
Montie, James E. ;
Varambally, Sooryanarayana ;
Mehra, Rohit ;
Chinnaiyan, Arul M. .
CANCER RESEARCH, 2008, 68 (01) :73-80
[20]   Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer [J].
Hermans, Karin G. ;
van der Korput, Hetty A. ;
van Marion, Ronald ;
van de Wijngaart, Dennis J. ;
Ziel-van der Made, Angelique ;
Dits, Natasja F. ;
Boormans, Joost L. ;
van der Kwast, Theo H. ;
van Dekken, Herman ;
Bangma, Chris H. ;
Korsten, Hanneke ;
Kraaij, Robert ;
Jenster, Guido ;
Trapman, Jan .
CANCER RESEARCH, 2008, 68 (18) :7541-7549